Human epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide

General information
 

Name:
Human epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide
Size:
100ug
Catalog no:
AB-23036-P
Price:
450 EUR
 

Additional extra details
 

  • Stock availability

    Available

    Category

    Primary Antibodies

    Antibody type

    Polyclonal Antibody

  • Antibody host

    Rabbit

    Antibody conjugate

    N/A

    Technical datasheet

    Contact Gentaur to request the datasheet or ask our specialists for more information.

  • Notes

    The Human epilepsy, progressive myoclonus type 2A (EPM2A) Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.

    Tissue

    control

    Test

    You can block the antibody by the specific target amino acid sequence of peptide.

  • Properties

    blocking peptide,Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.